BruntonM.MathenyJ. (2009) Divergent acceptance of change in a public health organization. Journal of Organizational Change Management22(6): 600–619.
2.
PentinaI.TaylorD. G.VoelkerT. A. (2009) The roles of self-discrepancy and social support in young females' decisions to undergo cosmetic procedures. Journal of Consumer Behaviour8(4): 149–165.
3.
MowenJ. C.LongoriaA.SalleeA. (2009) Burning and cutting: Identifying the traits of individuals with an enduring propensity to tan and to undergo cosmetic surgery. Journal of Consumer Behaviour8(5): 238–251.
4.
SchillingJ.KlugeA. (2009) Barriers to organizational learning: An integration of theory and research. International Journal of Management Reviews11(3): 337–360.
5.
RaoS. K. (2009) Re-energizing a product portfolio: Case study for a pharmaceutical merger. Journal of Business Strategy30(6): 52–62.
6.
JeongH. S. (2009) Pharmaceutical reforms: Implications through comparisons of Korea and Japan. Health Policy93(2/3): 165–171.
7.
TimonenJ.KarttunenP.BengtstramM.AhonenR. (2009) The impact of generic substitution on the turnover and gross margin of pharmaceutical companies a survey 1 year and 5 years after the introduction of generic substitution in Finland. Health Policy92(2/3): 116–123.
8.
DurranceC. (2009) The impact of pharmacy-specific any-willing-provider legislation on prescription drug expenditures. Atlantic Economic Journal37(4): 409–423.
9.
NickischK. J.GreuelJ. M.Bode-GreuelK. M. (2009) How can pharmaceutical and biotechnology companies maintain a high profitability?. Journal of Commercial Biotechnology15(4): 309–323.
10.
TijssenR. J. W. (2009) Internationalisation of pharmaceutical R&D: How globalised are Europe's largest multinational companies?. Technology Analysis & Strategic Management21(7): 859–879.
